Dr. Joseph Schulman

In 1969, Alfred Mann engaged Joe Schulman, Ph.D., to take nascent pacemaker technology from the Applied Physics Lab at Johns Hopkins University, miniaturize it, and set up a production line to manufacture it in commercial quantities, as well as to help develop new products. In 1973, four years and two major design changes later, the first commercial rechargeable cardiac pacemaker was implanted, and Pacesetter Systems Inc. was born. The device Pacesetter manufactured was the first pacemaker with two-way telemetry, which enabled a clinician to interrogate and review all the important electrical characteristics prior to programming. The device was also the first to use a rechargeable, long-life battery. These innovations and others developed by Pacesetter set a standard in the industry that other companies soon followed.

In 1985, Alfred Mann again engaged Joseph Schulman to become President and Chief Scientist of the Alfred Mann Foundation for Scientific Research, a non-profit research organization devoted to development of advanced medical products.

Throughout Dr. Schulman’s career he developed or initiated development of many leading edge medical products, such as the first reliable rechargeable cardiac pacemaker with bi-directional telemetry; a cochlear implant with bi-directional telemetry with analog and digital strategies; and an injectable neuro muscular stimulator to restore function to impaired limbs and body organs.

Dr. Schulman holds in excess of 40 patents and has authored many scientific, biomedical and engineering papers, posters and presentations. Dr. Schulman is a graduate of University of California, Los Angeles, with a B.S. in Applied Physics (Major: Spectroscopy) and a Ph.D in Zoology (Major: Neurophysiology; Minor: Genetics). Dr. Schulman is Adjunct Professor of Biomedical Engineering at the University of Southern California, Los Angeles and on the Advisory Board at the University of California, Los Angeles, Neuro Engineering Program.